he purpose of this report was to update the 2006 International League Against Epilepsy (ILAE) report and identify the level of evidence for long-term efficacy or effectiveness for antiepileptic drugs (AEDs) as initial monotherapy for patients with newly diagnosed or untreated epilepsy. All applicable articles from July 2005 until March 2012 were identified, evaluated, and combined with the previous ysis (Glauser et al., 2006) to provide a comprehensive update.
The prior ysis methodology was utilized with three modifications: (1) the detectable noninferiority boundary approach was dropped and both failed superiority studies and prespecified noninferiority studies were yzed using a noninferiority approach, (2) the definition of an adequate comparator was clarified and now includes an absolute minimum point estimate for efficacy/effectiveness, and (3) the relationship table between clinical trial ratings, level of evidence, and conclusions no longer includes a recommendation column to reinforce that this review of efficacy/evidence for specific seizure types does not imply treatment recommendations.
This evidence review contains one clarification: The commission has determined that class I superiority studies can be designed to detect up to a 20% absolute (rather than relative) difference in the point estimate of efficacy/effectiveness between study treatment and comparator using an intent-to-treat ysis. Since July, 2005, three class I randomized controlled trials (RCT) and 11 class III RCTs he been published. The combined ysis (1940-2012) now includes a total of 64 RCTs (7 with class I evidence, 2 with class II evidence) and 11 meta-yses.
New efficacy/effectiveness findings include the following: levetiracetam and zonisamide he level A evidence in s with partial onset seizures and both ethosuximide and valproic acid he level A evidence in children with childhood absence epilepsy.
There are no major changes in the level of evidence for any other subgroup. Levetiracetam and zonisamide join carbamazepine and phenytoin with level A efficacy/effectiveness evidence as initial monotherapy for s with partial onset seizures. Although ethosuximide and valproic acid now he level A efficacy/effectiveness evidence as initial monotherapy for children with absence seizures, there continues to be an alarming lack of well designed, properly conducted epilepsy RCTs for patients with generalized seizures/epilepsies and in children in general.
These findings reinforce the need for multicenter, multinational efforts to design, conduct, and yze future clinically relevant adequately designed RCTs. When selecting a patient's AED, all relevant variables and not just efficacy and effectiveness should be considered.
检视信源地址
上一页:老人癫痫病早期症状是什么
下一页:癫痫病的病征有什么
- 2022-04-272013年的国际抗癫痫联合会抗癫痫药使用指南
- 妇科解剖记忆公式有点长,非常详细!
- 中国还是成立新的疾控机构?大疾控局呼之欲出
- 炎症是性病吗?
- 白癜风会传染吗?
- 首例新冠肺炎患者长期勃起异常
- 哺乳期乳腺炎症状 教你如何预防哺乳期乳腺炎
- 最新研究 | 转移性乳腺癌一线化疗预后监测新突破
- 疾病新知:毛囊性白癜风
- 癫痫治疗障碍仍难以克服
- FDA批准开浦兰治疗1个月至4岁癫痫儿童
- 治疗白癜风的方法很多
- Eur Urol Focus:预测术后中度肾功能丧失的列线图
- 脑梗死的症状是什么有这些前兆要谨慎
- Semin Arthritis Rheu:银屑病关节炎的死亡率
- 【用药问答】癫痫发作和局限性发作的首选治疗是什么?
- 白癜风的遗传是什么?
- 综述:癫痫持续状态诊治最新进展
- 儿童癫痫的症状是什么?
- 癫痫患者手术评估新型工具
- 世界癫痫日 | 科学防治 标准诊疗 告别癫痫
- 你知道吗?快看护理知识!
- 广西百色破获药案:涉及74家药店,3000多盒
- 治疗白癜风的方法 牢记这些治疗白癜风更省钱
- Sci Rep:口服药物,或破坏阿尔茨海默病治疗僵局
- 白癜风患者的饮食调理
- 儿童癫痫的早期症状 癫痫的原因
- 如何自我诊断白癜风?
- 为什么身上有小白点 可能得了这种病?
- 癫痫病该怎么尽早预防呢
- 外科手术癫痫病偏方哪些好啊
- 花季少年突发癫痫 竟然脑中住着一位「君」
- 第五届 CAAE 国际抑郁症论坛
- PLoS ONE:新的合成抗原能快速激活免疫系统抵御流感
- 癫痫病是怎么回事 我们所不发觉的危害
- 成年人癫痫病怎么治疗好
- 治疗腹型癫痫病并不需要多少钱
- 美国神经病学协会的新指南有助医生为HIV患者更好地选择癫痫本品
- 癫痫病的以前症状 有这些症状小心癫痫病
- 头皮脑电图或功能磁共振成像对局灶性癫痫有定位关键作用
- 抑郁症可以治愈吗?抑郁症治疗新突破:基于病因诊断基础上的精准治疗